9-136412015-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015160.3(PMPCA):c.90C>T(p.Tyr30=) variant causes a synonymous change. The variant allele was found at a frequency of 0.17 in 1,608,390 control chromosomes in the GnomAD database, including 24,989 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.14 ( 1698 hom., cov: 33)
Exomes 𝑓: 0.17 ( 23291 hom. )
Consequence
PMPCA
NM_015160.3 synonymous
NM_015160.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.92
Genes affected
PMPCA (HGNC:18667): (peptidase, mitochondrial processing subunit alpha) The protein encoded by this gene is found in the mitochondrion, where it represents the alpha subunit of a proteolytic heterodimer. This heterodimer is responsible for cleaving the transit peptide from nuclear-encoded mitochondrial proteins. Defects in this gene are a cause of spinocerebellar ataxia, autosomal recessive 2. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 9-136412015-C-T is Benign according to our data. Variant chr9-136412015-C-T is described in ClinVar as [Benign]. Clinvar id is 1220620.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.207 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PMPCA | NM_015160.3 | c.90C>T | p.Tyr30= | synonymous_variant | 2/13 | ENST00000371717.8 | |
PMPCA | XM_005266059.4 | c.90C>T | p.Tyr30= | synonymous_variant | 2/12 | ||
PMPCA | NM_001282944.2 | c.-209C>T | 5_prime_UTR_variant | 2/12 | |||
PMPCA | NM_001282946.2 | c.-209C>T | 5_prime_UTR_variant | 2/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PMPCA | ENST00000371717.8 | c.90C>T | p.Tyr30= | synonymous_variant | 2/13 | 1 | NM_015160.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.136 AC: 20728AN: 152112Hom.: 1691 Cov.: 33
GnomAD3 genomes
AF:
AC:
20728
AN:
152112
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.167 AC: 41765AN: 249804Hom.: 3906 AF XY: 0.165 AC XY: 22260AN XY: 135184
GnomAD3 exomes
AF:
AC:
41765
AN:
249804
Hom.:
AF XY:
AC XY:
22260
AN XY:
135184
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.174 AC: 253425AN: 1456160Hom.: 23291 Cov.: 31 AF XY: 0.173 AC XY: 125691AN XY: 724660
GnomAD4 exome
AF:
AC:
253425
AN:
1456160
Hom.:
Cov.:
31
AF XY:
AC XY:
125691
AN XY:
724660
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.136 AC: 20744AN: 152230Hom.: 1698 Cov.: 33 AF XY: 0.134 AC XY: 9984AN XY: 74420
GnomAD4 genome
AF:
AC:
20744
AN:
152230
Hom.:
Cov.:
33
AF XY:
AC XY:
9984
AN XY:
74420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
543
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Autosomal recessive spinocerebellar ataxia 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Oct 25, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at